Skip to main content
Aurora Cannabis Inc. logo

Aurora Cannabis Inc. — Investor Relations & Filings

Ticker · ACB ISIN · CA05156X8504 TSX Manufacturing
Open in API
Filings indexed 364 across all filing types
Latest filing 2025-08-06 Regulatory Filings
Country CA Canada
Listing TSX ACB

About Aurora Cannabis Inc.

https://www.auroramj.com/

Aurora Cannabis Inc. is a global leader in the production and distribution of cannabis and cannabis-derivative products. The company cultivates and sells a portfolio of products for both medicinal and recreational markets. Recognized as Canada's largest medical cannabis company and a trusted provider, Aurora focuses on innovative, science-based medical cannabis offerings, including dried flower and various derivative formats such as oils and edibles. The company maintains operations across 12 countries, emphasizing high-quality cultivation and rigorous product development to serve patients and consumers worldwide.

Recent filings

Filing Released Lang Actions
52-109F2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 89% confidence The document is a Form 52-109F2 “Certification of Interim Filings” by the CFO under Canadian National Instrument 52-109. It is a standalone regulatory certificate accompanying interim financial statements and MD&A, not the full interim report (IR) itself nor an auditor’s opinion (AR). It does not contain comprehensive financial data or narrative management discussion, but rather the formal certification of controls and filings. No specific category exists for certification letters – it is best classified under the general Regulatory Filings fallback. Therefore, the correct classification is RNS.
2025-08-06 English
Interim MD&A - English.pdf
Management Reports Classification · 90% confidence The document is titled “Management’s Discussion & Analysis” (MD&A) for the first quarter of fiscal 2026, covering the three months ended June 30, 2025. It provides detailed management commentary on financial results, business trends, outlook, and reconciliations of non-GAAP measures under IFRS. It is not an earnings release or a brief announcement, but a comprehensive interim management discussion, fitting the definition of a Management Report (MD&A). Therefore, it should be classified as MDA.
2025-08-06 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Condensed Consolidated Financial Statements' for Aurora Cannabis Inc. for the three months ended June 30, 2025. It contains comprehensive financial statements (Statement of Financial Position, Statement of Income/Comprehensive Income, Statement of Changes in Shareholders' Equity, and Statement of Cash Flows) along with detailed notes. This fits the definition of an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. Q2 2025
2025-08-06 English
News release - English.pdf
Regulatory Filings
2025-08-06 English
News release - English.pdf
Proxy Solicitation & Information Statement Classification · 82% confidence The document is a press release reminding shareholders to vote in advance of the Company’s Annual General and Special Meeting and provides instructions for proxy voting and contact details for the proxy solicitation agent. It does not contain actual financial results, board changes, or voting results, nor is it the full AGM materials or an annual report. Instead, it is soliciting proxies and directing shareholders to review meeting materials. This aligns with the definition of a Proxy Solicitation & Information Statement (PSI).
2025-07-30 English
News release - English.pdf
Regulatory Filings
2025-07-23 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.